By harnessing the body’s immune system to detect and destroy tumor cells, immune checkpoint inhibitors are rapidly ushering in a new era of precision medicine. Although immune checkpoint inhibitors have demonstrated durable clinical responses across several tumor types, these therapies are costly and may present toxic side effects.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1 Voena & Chiarle. Discov Med 2016; 21:125-33.

Comprehensive genomic and proteomic profiling with Caris Molecular Intelligence can help you make more informed therapy decisions when considering immune checkpoint inhibitors.